Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Broad-based index products are expected to increase the Y share of personal pension, and personal pension products are expected to expand after the second anniversary of the personal pension system. It is understood that mainstream broad-based index products are expected to increase the personal pension Y share, including Shanghai and Shenzhen 300 Index, CSI 500 Index, CSI A500 Index, GEM Index and other products, which can provide investors with more allocation needs. (SSE)The new work of the famous horror film series Death Comes 6 is scheduled in North America. On May 16th next year, the new work of the famous horror film series Death Comes 6 is scheduled. The film will be released in North America on May 16th next year to commemorate the 25th anniversary of the series.
"Nature" announced the top ten figures in 2024, and two China scientists were selected. On the 9th, the website of the British magazine "Nature" released the list of the top ten figures promoting scientific development in 2024. Among them, two China scientists were selected. The list was compiled by the editors of Nature magazine to record the important scientific progress, events and some key figures this year. Among them, two China researchers who were selected as the top ten were Xu Huji, a rheumatologist from the PLA Naval Medical University, and Li Chunlai, deputy chief designer of the Chang 'e VI mission and a researcher at the National Astronomical Observatory of the Chinese Academy of Sciences. Dr. Xu Huji bravely tried to treat autoimmune diseases with CAR-T cell therapy, which brought hope for the mass production of CAR-T cell therapy. Li Chunlai was a key figure in determining the landing site of Chang 'e-6 probe on the moon, and was also one of the first scientists to analyze the returned samples.Musk showed that robots conquer rugged terrain without relying on visual system. Tesla released a video showing the latest progress of its humanoid robot Optimus walking on complex terrain. The video shows that Optimus can walk steadily on a hill slope covered with mulch. Tesla CEO Elon Musk said on social media that the robot can control its electric limbs through neural networks and can walk on this rugged terrain without remote control.China Heihe-Russia Kanikurgan Highway Port Passenger Transport was officially opened. On December 10th, with the first passenger completing the exit formalities, China Heihe Highway Port-Russia Kanikurgan Highway Port Passenger Transport was officially opened. Passengers take buses from Heihe International Highway Passenger Station in China and Amoula Suo International Bus Station in Blagoveshchensk, Russia, respectively, and cross the Sino-Russian cross-border highway bridge, with four buses entering and leaving each country every day. After the official opening of passenger transportation at Heihe Highway Port, the functions of Sino-Russian highway ports have been further improved, providing a more convenient channel for cross-border communication. (Xinhua News Agency)
Indian Rupee hit an all-time low, while Indian Rupee hit a low of 84.80 against the US dollar in early trading, surpassing the all-time low of 84.7575 hit last week. India's central bank may step in to support the rupee, and traders point out that state-owned banks have sold dollars.Minister of Malaysia: ZTE will invest 200 million ringgit in Malaysia.Australia's policy interest rate is 4.35%, expected to be 4.35%, and the previous value is 4.35%.
Strategy guide 12-13
Strategy guide